A series of e-mail exchanges between HHS officials shows growing alarm at the amount of projected profit from a government contract for a drug company whose controlling shareholder is a longtime Democratic Party activist.
E-mails questioned huge contract for firm with ties to Obama administration
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.